Project: lionikas_2014
530 significantly associated models · 118 unique genes
# | chr | p0 | p1 | # assoc genes | # joint models | best TWAS P | best SNP P | cond SNP P | % var exp | joint genes |
---|---|---|---|---|---|---|---|---|---|---|
1 | 1 | 186942049 | 188155947 | 1 | 1 | 1.4e-07 | 1.2e-07 | 6.2e-07 | 11 | Eef1akmt2 |
2 | 1 | 188769728 | 190166526 | 1 | 1 | 3.0e-07 | 1.1e-08 | 1.0e-02 | 80 | Dock1 |
3 | 3 | 45965821 | 47365160 | 1 | 1 | 1.1e-07 | 1.1e-06 | 3.6e-01 | 96 | Slc4a10 |
4 | 7 | 26575816 | 30734621 | 19 | 1 | 5.5e-11 | 9.6e-11 | 1.0e-02 | 84 | Vezt |
5 | 7 | 128990726 | 130910330 | 3 | 1 | 2.7e-07 | 2.7e-07 | 1.0e+00 | 100 | Prph |
6 | 8 | 108584253 | 109479622 | 1 | 1 | 2.8e-08 | 9.2e-05 | 8.6e-02 | 81 | Apeh |
7 | 8 | 110189566 | 111564791 | 1 | 1 | 2.3e-07 | 9.4e-07 | 1.0e+00 | 100 | Als2cl |
8 | 10 | 102999385 | 107195627 | 79 | 6 | 6.7e-15 | 2.5e-14 | NaN | NaN | Aatk Tbcd Gaa Ccdc137 Sgsh NA |
9 | 14 | 95819498 | 97690688 | 5 | 3 | 2.0e-08 | 1.2e-07 | 1.0e+00 | 100 | B3gnt2 NA Zrsr1 |
10 | 15 | 47167781 | 50742046 | 7 | 1 | 1.3e-08 | 9.2e-09 | 1.0e+00 | 100 | Nudt15 |
p0: physical position of the start of the locus. p1: physical position of the end of the locus. # joint models: number of models selected by step-wise conditional analysis.
chisq ratio: Average Chi2 statistic for the selected genes in the secondary trait, divided by the average statistic for all genes in the secondary trait. # genes+: Shared significant genes at Bonferroni correction. # genes++: Shared significant genes at transcriptome-wide significance. % genes++: Number of [++] genes as a percentage of primary trait’s total joint genes. corr: Correlation of effect sizes across the [+] genes.
tissue | modality | # hits | % hits/tests | avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 14 | 0.660 | 3.1 |
Adipose | alternative TSS | 0 | 0.000 | 2.8 |
Adipose | gene expression | 37 | 0.446 | 2.7 |
Adipose | isoform ratio | 8 | 0.284 | 2.8 |
Adipose | intron excision ratio | 15 | 0.514 | 2.9 |
Adipose | mRNA stability | 16 | 0.463 | 2.8 |
BLA | alternative polyA | 0 | 0.000 | 2.9 |
BLA | alternative TSS | 1 | 0.119 | 2.9 |
BLA | gene expression | 23 | 0.380 | 2.7 |
BLA | isoform ratio | 1 | 0.057 | 2.8 |
BLA | intron excision ratio | 10 | 0.335 | 3.0 |
BLA | mRNA stability | 9 | 0.445 | 2.8 |
Brain | alternative polyA | 6 | 0.299 | 2.9 |
Brain | alternative TSS | 6 | 0.350 | 2.9 |
Brain | gene expression | 29 | 0.320 | 2.7 |
Brain | isoform ratio | 8 | 0.253 | 2.7 |
Brain | intron excision ratio | 24 | 0.444 | 3.0 |
Brain | mRNA stability | 19 | 0.435 | 2.7 |
Eye | alternative polyA | 0 | 0.000 | 2.8 |
Eye | alternative TSS | 2 | 0.833 | 3.3 |
Eye | gene expression | 1 | 0.089 | 2.9 |
Eye | isoform ratio | 1 | 0.282 | 3.0 |
Eye | intron excision ratio | 1 | 0.163 | 2.6 |
Eye | mRNA stability | 1 | 0.429 | 3.0 |
IL | alternative polyA | 3 | 0.493 | 3.2 |
IL | alternative TSS | 0 | 0.000 | 2.7 |
IL | gene expression | 9 | 0.247 | 2.7 |
IL | isoform ratio | 3 | 0.381 | 3.0 |
IL | intron excision ratio | 4 | 0.415 | 3.0 |
IL | mRNA stability | 5 | 0.450 | 2.7 |
LHb | alternative polyA | 4 | 0.698 | 3.1 |
LHb | alternative TSS | 0 | 0.000 | 2.7 |
LHb | gene expression | 7 | 0.218 | 2.8 |
LHb | isoform ratio | 3 | 0.398 | 3.0 |
LHb | intron excision ratio | 6 | 0.583 | 3.1 |
LHb | mRNA stability | 5 | 0.483 | 2.8 |
Liver | alternative polyA | 7 | 0.467 | 3.1 |
Liver | alternative TSS | 11 | 0.726 | 2.9 |
Liver | gene expression | 35 | 0.487 | 2.7 |
Liver | isoform ratio | 8 | 0.335 | 2.8 |
Liver | intron excision ratio | 32 | 0.731 | 2.8 |
Liver | mRNA stability | 10 | 0.407 | 2.8 |
NAcc | alternative polyA | 0 | 0.000 | 3.1 |
NAcc | alternative TSS | 0 | 0.000 | 3.3 |
NAcc | gene expression | 4 | 0.122 | 2.8 |
NAcc | isoform ratio | 2 | 0.270 | 2.8 |
NAcc | intron excision ratio | 2 | 0.210 | 2.9 |
NAcc | mRNA stability | 2 | 0.185 | 2.9 |
NAcc2 | alternative polyA | 0 | 0.000 | 2.8 |
NAcc2 | alternative TSS | 4 | 0.548 | 3.1 |
NAcc2 | gene expression | 16 | 0.300 | 2.8 |
NAcc2 | isoform ratio | 2 | 0.130 | 2.7 |
NAcc2 | intron excision ratio | 10 | 0.378 | 2.9 |
NAcc2 | mRNA stability | 7 | 0.392 | 2.7 |
OFC | alternative polyA | 0 | 0.000 | 2.9 |
OFC | alternative TSS | 0 | 0.000 | 3.1 |
OFC | gene expression | 12 | 0.324 | 2.8 |
OFC | isoform ratio | 0 | 0.000 | 2.7 |
OFC | intron excision ratio | 5 | 0.498 | 3.4 |
OFC | mRNA stability | 4 | 0.370 | 2.9 |
PL | alternative polyA | 2 | 0.334 | 3.1 |
PL | alternative TSS | 0 | 0.000 | 2.8 |
PL | gene expression | 10 | 0.269 | 2.7 |
PL | isoform ratio | 1 | 0.115 | 2.9 |
PL | intron excision ratio | 5 | 0.480 | 2.9 |
PL | mRNA stability | 7 | 0.609 | 2.9 |
PL2 | alternative polyA | 1 | 0.080 | 2.9 |
PL2 | alternative TSS | 0 | 0.000 | 3.1 |
PL2 | gene expression | 19 | 0.297 | 2.7 |
PL2 | isoform ratio | 5 | 0.271 | 2.8 |
PL2 | intron excision ratio | 13 | 0.413 | 3.0 |
PL2 | mRNA stability | 13 | 0.533 | 2.9 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.